Seeking Alpha
 

BioMarin Pharmaceutical Inc. (BMRN)

- NASDAQ
There is research on this stock available only to PRO subscribers.
From other sites
Visit Seeking Alpha's
BMRN vs. ETF Alternatives
Company Description
Biomarin Pharmaceutical Inc develops and commercializes pharmaceuticals for serious diseases and medical conditions. Its product portfolio is comprised of five product candidates Naglazyme, Kuvan, Aldurazyme, VIMIZIM and Firdapse.
Sector: Healthcare
Industry: Biotechnology
Country: United States